从中国血管成形及支架置入术治疗症状性重度颅内动脉狭窄(CASSISS)研究看非急性缺血性卒中诊治的未来  

Future treatment of non-acute ischemic stroke: lecture from CASSISS

作　　者：王韬 罗继昌 焦力群[2] Wang Tao;Luo Jichang;Jiao Liqun(Department of Neurosurgery,Xuanwu Hospital,Capital Medical University,Beijing 100053,China)

机构地区：[1]首都医科大学宣武医院神经外科,北京100053 [2]首都医科大学宣武医院介入放射科,北京100053

出　　处：《中国脑血管病杂志》2023年第3期145-149,共5页Chinese Journal of Cerebrovascular Diseases

摘　　要：中国血管成形及支架置入术治疗症状性重度颅内动脉狭窄(CASSISS)研究的阴性结局并不意味着研究失败,其结果提示,对于颅内动脉狭窄的认识目前还处于浅薄的状态,该研究并不是颅内动脉狭窄血管内治疗的终点,而恰恰是起点。作为神经介入医师,应更加注重利用评估手段对患者进行精准的筛选,而并非一味强调血管内治疗技术的提升。此外,未来颅内动脉狭窄的临床研究应该关注患者的认知功能评估,而不是仅关注临床卒中复发风险。The negative outcome of China angioplasty and stenting for symptomatic intracranial severe stenosis(CASSISS)does not imply that the study was ineffective.This study demonstrated that the current understanding of intracranial artery stenosis is still shallow.This study is not the end of endovascular treatment for intracranial artery stenosis but the beginning instead.It is suggested that neuro-interventionists should place increased emphasis on accurate patient selection by utilizing available assessment tools,rather than enhancing endovascular treatment techniques.Furthermore,future clinical studies for intracranial artery stenosis should consider cognitive function rather than solely on the risk of stroke recurrence.

关 键 词：CASSISS 颅内动脉狭窄 支架置入 药物治疗 

分 类 号：R743.3[医药卫生—神经病学与精神病学]